Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy after mRNA COVID19 vaccination-Reference-Cited by-同舟云学术

Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy after mRNA COVID19 vaccination

Published:2022-12 Issue:12 Volume:21 Page:103201
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Rowe Simon,Spies Judith M.,Urriola Nicolás

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference6 articles.

1. Multimodal biomarkers quantify recovery in autoimmune autonomic ganglionopathy;Koay;Ann Neurol,2021

2. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies;Vernino;N Engl J Med,2000

3. A flow cytometric assay to detect functional ganglionic acetylcholine receptor antibodies by immunomodulation in autoimmune autonomic ganglionopathy;Urriola;Front Immunol [online serial],2021

4. Autoimmune autonomic ganglionopathy: ganglionic acetylcholine receptor autoantibodies;Urriola;Autoimmun Rev,2021

5. Autonomic dysfunction following COVID-19 infection: an early experience;Shouman;Clin Auton Res,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination;Frontiers in Neurology;2023-08-16

2. Tozinameran;Reactions Weekly;2023-04-15

3. Therapeutic Approaches to Dysautonomia in Childhood, with a Special Focus on Long COVID;Children;2023-02-07

4. Severe treatment-refractory antibody positive autoimmune autonomic ganglionopathy and COVID19 vaccination: Correspondence;Autoimmunity Reviews;2023-02